Remove Pharma Companies Remove Pharma Production Remove Research Remove Trials
article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.

article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharma production to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.

article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

My background for decades now is in the pharma marketing and branding space, working with all sorts of pharma products, devices, diagnostics. Working in both marketing and advertising campaigns but also market research, strategic planning, workshop facilitation. Do you connect patients with the clinical trial folks?

Doctors 40